This result is in agreement with a larger breast cancer cohort investigation (n =293) [30], and strongly suggests that the regulation of p53 levels affect patients’ prognosis and that appropriate levels of p53 are essential for maintaining genomic stability. Here, TP53 is linked to breast carcinoma.